nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—breast cancer	0.321	1	CiPCiCtD
Pemetrexed—Methotrexate—breast cancer	0.203	1	CrCtD
Pemetrexed—TYMS—breast cancer	0.0836	1	CbGaD
Pemetrexed—Pralatrexate—Methotrexate—breast cancer	0.0268	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—breast cancer	0.0268	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—breast cancer	0.0268	0.2	CrCrCtD
Pemetrexed—Folic Acid—Methotrexate—breast cancer	0.0268	0.2	CrCrCtD
Pemetrexed—Leucovorin—Methotrexate—breast cancer	0.0268	0.2	CrCrCtD
Pemetrexed—TYMS—Capecitabine—breast cancer	0.0223	0.147	CbGbCtD
Pemetrexed—ATIC—Methotrexate—breast cancer	0.0206	0.136	CbGbCtD
Pemetrexed—SLC29A1—Gemcitabine—breast cancer	0.0166	0.11	CbGbCtD
Pemetrexed—SLC46A1—Methotrexate—breast cancer	0.0163	0.108	CbGbCtD
Pemetrexed—DCK—Gemcitabine—breast cancer	0.0154	0.102	CbGbCtD
Pemetrexed—TYMS—Gemcitabine—breast cancer	0.0154	0.102	CbGbCtD
Pemetrexed—SLC29A1—Fluorouracil—breast cancer	0.0142	0.0938	CbGbCtD
Pemetrexed—TYMS—Fluorouracil—breast cancer	0.0132	0.0869	CbGbCtD
Pemetrexed—DHFR—Methotrexate—breast cancer	0.0104	0.0688	CbGbCtD
Pemetrexed—TYMS—Methotrexate—breast cancer	0.00728	0.0479	CbGbCtD
Pemetrexed—GART—nipple—breast cancer	0.000779	0.0449	CbGeAlD
Pemetrexed—ATIC—mammary gland—breast cancer	0.00064	0.0369	CbGeAlD
Pemetrexed—GART—endometrium—breast cancer	0.00047	0.0271	CbGeAlD
Pemetrexed—ATIC—embryo—breast cancer	0.000437	0.0252	CbGeAlD
Pemetrexed—GART—pituitary gland—breast cancer	0.000426	0.0245	CbGeAlD
Pemetrexed—GART—adipose tissue—breast cancer	0.000424	0.0244	CbGeAlD
Pemetrexed—GART—female reproductive system—breast cancer	0.00039	0.0225	CbGeAlD
Pemetrexed—SLC29A1—mammary gland—breast cancer	0.000389	0.0224	CbGeAlD
Pemetrexed—GART—adrenal gland—breast cancer	0.00038	0.0219	CbGeAlD
Pemetrexed—GART—bone marrow—breast cancer	0.000368	0.0212	CbGeAlD
Pemetrexed—ATIC—epithelium—breast cancer	0.000356	0.0205	CbGeAlD
Pemetrexed—DHFR—nipple—breast cancer	0.000355	0.0205	CbGeAlD
Pemetrexed—GART—female gonad—breast cancer	0.000355	0.0204	CbGeAlD
Pemetrexed—SLC46A1—pituitary gland—breast cancer	0.000346	0.0199	CbGeAlD
Pemetrexed—ATIC—skin of body—breast cancer	0.000339	0.0195	CbGeAlD
Pemetrexed—Tetrahydrofolic acid—SHMT1—breast cancer	0.000337	0.253	CrCbGaD
Pemetrexed—GART—endocrine gland—breast cancer	0.00033	0.019	CbGeAlD
Pemetrexed—SLC29A1—nipple—breast cancer	0.000322	0.0185	CbGeAlD
Pemetrexed—SLC46A1—adrenal gland—breast cancer	0.000309	0.0178	CbGeAlD
Pemetrexed—DCK—nipple—breast cancer	0.000307	0.0177	CbGeAlD
Pemetrexed—ATIC—uterus—breast cancer	0.000294	0.017	CbGeAlD
Pemetrexed—DHFR—embryo—breast cancer	0.000293	0.0169	CbGeAlD
Pemetrexed—ATIC—adipose tissue—breast cancer	0.000288	0.0166	CbGeAlD
Pemetrexed—SLC46A1—female gonad—breast cancer	0.000288	0.0166	CbGeAlD
Pemetrexed—SLC46A1—endocrine gland—breast cancer	0.000268	0.0154	CbGeAlD
Pemetrexed—ATIC—female reproductive system—breast cancer	0.000265	0.0152	CbGeAlD
Pemetrexed—ATIC—adrenal gland—breast cancer	0.000258	0.0149	CbGeAlD
Pemetrexed—DCK—embryo—breast cancer	0.000254	0.0146	CbGeAlD
Pemetrexed—ATIC—female gonad—breast cancer	0.000241	0.0139	CbGeAlD
Pemetrexed—TYMS—skin of body—breast cancer	0.00023	0.0132	CbGeAlD
Pemetrexed—GART—lymph node—breast cancer	0.000228	0.0131	CbGeAlD
Pemetrexed—ATIC—endocrine gland—breast cancer	0.000224	0.0129	CbGeAlD
Pemetrexed—TYMS—endometrium—breast cancer	0.000217	0.0125	CbGeAlD
Pemetrexed—DHFR—endometrium—breast cancer	0.000215	0.0124	CbGeAlD
Pemetrexed—DHFR—uterus—breast cancer	0.000198	0.0114	CbGeAlD
Pemetrexed—TYMS—adipose tissue—breast cancer	0.000195	0.0113	CbGeAlD
Pemetrexed—SLC29A1—endometrium—breast cancer	0.000194	0.0112	CbGeAlD
Pemetrexed—DHFR—pituitary gland—breast cancer	0.000194	0.0112	CbGeAlD
Pemetrexed—DHFR—adipose tissue—breast cancer	0.000193	0.0111	CbGeAlD
Pemetrexed—DCK—endometrium—breast cancer	0.000186	0.0107	CbGeAlD
Pemetrexed—SLC46A1—lymph node—breast cancer	0.000185	0.0107	CbGeAlD
Pemetrexed—TYMS—female reproductive system—breast cancer	0.000179	0.0103	CbGeAlD
Pemetrexed—SLC29A1—uterus—breast cancer	0.000179	0.0103	CbGeAlD
Pemetrexed—DHFR—female reproductive system—breast cancer	0.000178	0.0102	CbGeAlD
Pemetrexed—SLC29A1—pituitary gland—breast cancer	0.000176	0.0101	CbGeAlD
Pemetrexed—TYMS—adrenal gland—breast cancer	0.000175	0.0101	CbGeAlD
Pemetrexed—SLC29A1—adipose tissue—breast cancer	0.000175	0.0101	CbGeAlD
Pemetrexed—DHFR—adrenal gland—breast cancer	0.000173	0.00999	CbGeAlD
Pemetrexed—Tetrahydrofolic acid—MTR—breast cancer	0.000172	0.129	CrCbGaD
Pemetrexed—DCK—uterus—breast cancer	0.000171	0.00986	CbGeAlD
Pemetrexed—TYMS—bone marrow—breast cancer	0.000169	0.00976	CbGeAlD
Pemetrexed—DCK—pituitary gland—breast cancer	0.000168	0.00968	CbGeAlD
Pemetrexed—DHFR—bone marrow—breast cancer	0.000168	0.00967	CbGeAlD
Pemetrexed—DCK—adipose tissue—breast cancer	0.000167	0.00964	CbGeAlD
Pemetrexed—TYMS—female gonad—breast cancer	0.000163	0.00941	CbGeAlD
Pemetrexed—DHFR—female gonad—breast cancer	0.000162	0.00932	CbGeAlD
Pemetrexed—SLC29A1—female reproductive system—breast cancer	0.000161	0.00927	CbGeAlD
Pemetrexed—SLC29A1—adrenal gland—breast cancer	0.000157	0.00905	CbGeAlD
Pemetrexed—ATIC—lymph node—breast cancer	0.000155	0.00892	CbGeAlD
Pemetrexed—DCK—female reproductive system—breast cancer	0.000154	0.00886	CbGeAlD
Pemetrexed—SLC29A1—bone marrow—breast cancer	0.000152	0.00876	CbGeAlD
Pemetrexed—TYMS—endocrine gland—breast cancer	0.000152	0.00875	CbGeAlD
Pemetrexed—Raltitrexed—TYMS—breast cancer	0.000152	0.114	CrCbGaD
Pemetrexed—DHFR—endocrine gland—breast cancer	0.00015	0.00867	CbGeAlD
Pemetrexed—DCK—adrenal gland—breast cancer	0.00015	0.00865	CbGeAlD
Pemetrexed—SLC29A1—female gonad—breast cancer	0.000146	0.00844	CbGeAlD
Pemetrexed—DCK—bone marrow—breast cancer	0.000145	0.00836	CbGeAlD
Pemetrexed—DCK—female gonad—breast cancer	0.00014	0.00806	CbGeAlD
Pemetrexed—SLC29A1—endocrine gland—breast cancer	0.000136	0.00785	CbGeAlD
Pemetrexed—DCK—endocrine gland—breast cancer	0.00013	0.0075	CbGeAlD
Pemetrexed—TYMS—Docetaxel—Paclitaxel—breast cancer	0.000116	0.128	CbGdCrCtD
Pemetrexed—Pralatrexate—TYMS—breast cancer	0.000115	0.0864	CrCbGaD
Pemetrexed—Leucovorin—TYMS—breast cancer	0.000115	0.0864	CrCbGaD
Pemetrexed—TYMS—Gefitinib—Lapatinib—breast cancer	0.000114	0.126	CbGdCrCtD
Pemetrexed—DCK—Topotecan—Irinotecan—breast cancer	0.00011	0.121	CbGdCrCtD
Pemetrexed—TYMS—lymph node—breast cancer	0.000105	0.00605	CbGeAlD
Pemetrexed—DHFR—lymph node—breast cancer	0.000104	0.00599	CbGeAlD
Pemetrexed—SLC29A1—lymph node—breast cancer	9.42e-05	0.00543	CbGeAlD
Pemetrexed—DCK—lymph node—breast cancer	8.99e-05	0.00518	CbGeAlD
Pemetrexed—Methotrexate—SLCO1B1—breast cancer	7.09e-05	0.0533	CrCbGaD
Pemetrexed—Tetrahydrofolic acid—MTHFR—breast cancer	5.89e-05	0.0443	CrCbGaD
Pemetrexed—Folic Acid—MTHFR—breast cancer	5.89e-05	0.0443	CrCbGaD
Pemetrexed—Methotrexate—ABCC1—breast cancer	5.86e-05	0.044	CrCbGaD
Pemetrexed—TYMS—Paclitaxel—Docetaxel—breast cancer	5.81e-05	0.064	CbGdCrCtD
Pemetrexed—DCK—Epirubicin—Idarubicin—breast cancer	5.63e-05	0.0621	CbGdCrCtD
Pemetrexed—DCK—Doxorubicin—Idarubicin—breast cancer	5.63e-05	0.0621	CbGdCrCtD
Pemetrexed—DCK—Clomifene—Toremifene—breast cancer	5.39e-05	0.0594	CbGdCrCtD
Pemetrexed—Methotrexate—TYMS—breast cancer	5.07e-05	0.0381	CrCbGaD
Pemetrexed—Folic Acid—ABCG2—breast cancer	4.51e-05	0.0339	CrCbGaD
Pemetrexed—Methotrexate—MTHFR—breast cancer	4.03e-05	0.0303	CrCbGaD
Pemetrexed—TYMS—Vincristine—Vinorelbine—breast cancer	3.99e-05	0.044	CbGdCrCtD
Pemetrexed—TYMS—Vinorelbine—Vinblastine—breast cancer	3.73e-05	0.0412	CbGdCrCtD
Pemetrexed—DCK—Clomifene—Tamoxifen—breast cancer	3.38e-05	0.0373	CbGdCrCtD
Pemetrexed—TYMS—Vinblastine—Vinorelbine—breast cancer	3.21e-05	0.0354	CbGdCrCtD
Pemetrexed—TYMS—Vincristine—Vinblastine—breast cancer	3.19e-05	0.0352	CbGdCrCtD
Pemetrexed—DCK—Desoximetasone—Fluoxymesterone—breast cancer	3.17e-05	0.0349	CbGdCrCtD
Pemetrexed—Methotrexate—ABCG2—breast cancer	3.09e-05	0.0232	CrCbGaD
Pemetrexed—DCK—Doxorubicin—Epirubicin—breast cancer	2.58e-05	0.0285	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	2.57e-05	0.0283	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	2.51e-05	0.0277	CbGdCrCtD
Pemetrexed—DCK—Epirubicin—Doxorubicin—breast cancer	2.39e-05	0.0264	CbGdCrCtD
Pemetrexed—TYMS—Danazol—Fluoxymesterone—breast cancer	1.94e-05	0.0214	CbGdCrCtD
Pemetrexed—TYMS—Azacitidine—Gemcitabine—breast cancer	1.5e-05	0.0166	CbGdCrCtD
Pemetrexed—Methotrexate—ALB—breast cancer	1.35e-05	0.0101	CrCbGaD
Pemetrexed—Methotrexate—ABCB1—breast cancer	1.29e-05	0.00965	CrCbGaD
Pemetrexed—Arthralgia—Capecitabine—breast cancer	1.02e-05	0.000205	CcSEcCtD
Pemetrexed—Chest pain—Capecitabine—breast cancer	1.02e-05	0.000205	CcSEcCtD
Pemetrexed—Myalgia—Capecitabine—breast cancer	1.02e-05	0.000205	CcSEcCtD
Pemetrexed—Pain—Paclitaxel—breast cancer	1.02e-05	0.000205	CcSEcCtD
Pemetrexed—Constipation—Paclitaxel—breast cancer	1.02e-05	0.000205	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—breast cancer	1.01e-05	0.000204	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	1.01e-05	0.000203	CcSEcCtD
Pemetrexed—Urinary tract disorder—Methotrexate—breast cancer	1.01e-05	0.000203	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Epirubicin—breast cancer	1.01e-05	0.000203	CcSEcCtD
Pemetrexed—Oedema—Docetaxel—breast cancer	1.01e-05	0.000203	CcSEcCtD
Pemetrexed—Anaphylactic shock—Docetaxel—breast cancer	1.01e-05	0.000203	CcSEcCtD
Pemetrexed—Pruritus—Gemcitabine—breast cancer	1e-05	0.000202	CcSEcCtD
Pemetrexed—Nausea—Thiotepa—breast cancer	1e-05	0.000202	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—breast cancer	1e-05	0.000202	CcSEcCtD
Pemetrexed—Infection—Docetaxel—breast cancer	1e-05	0.000202	CcSEcCtD
Pemetrexed—Diarrhoea—Mitoxantrone—breast cancer	9.98e-06	0.000201	CcSEcCtD
Pemetrexed—Diarrhoea—Irinotecan—breast cancer	9.98e-06	0.000201	CcSEcCtD
Pemetrexed—Agranulocytosis—Epirubicin—breast cancer	9.95e-06	0.0002	CcSEcCtD
Pemetrexed—Shock—Docetaxel—breast cancer	9.92e-06	0.0002	CcSEcCtD
Pemetrexed—Nervous system disorder—Docetaxel—breast cancer	9.88e-06	0.000199	CcSEcCtD
Pemetrexed—Pruritus—Fluorouracil—breast cancer	9.88e-06	0.000199	CcSEcCtD
Pemetrexed—Thrombocytopenia—Docetaxel—breast cancer	9.87e-06	0.000199	CcSEcCtD
Pemetrexed—Infestation NOS—Doxorubicin—breast cancer	9.86e-06	0.000198	CcSEcCtD
Pemetrexed—Infestation—Doxorubicin—breast cancer	9.86e-06	0.000198	CcSEcCtD
Pemetrexed—Skin disorder—Docetaxel—breast cancer	9.79e-06	0.000197	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Doxorubicin—breast cancer	9.78e-06	0.000197	CcSEcCtD
Pemetrexed—Oedema—Capecitabine—breast cancer	9.76e-06	0.000196	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Paclitaxel—breast cancer	9.72e-06	0.000196	CcSEcCtD
Pemetrexed—Diarrhoea—Gemcitabine—breast cancer	9.72e-06	0.000196	CcSEcCtD
Pemetrexed—Renal failure—Doxorubicin—breast cancer	9.69e-06	0.000195	CcSEcCtD
Pemetrexed—Infection—Capecitabine—breast cancer	9.69e-06	0.000195	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—breast cancer	9.67e-06	0.000195	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Doxorubicin—breast cancer	9.67e-06	0.000195	CcSEcCtD
Pemetrexed—Dizziness—Irinotecan—breast cancer	9.64e-06	0.000194	CcSEcCtD
Pemetrexed—Stomatitis—Doxorubicin—breast cancer	9.61e-06	0.000193	CcSEcCtD
Pemetrexed—Anorexia—Docetaxel—breast cancer	9.61e-06	0.000193	CcSEcCtD
Pemetrexed—Shock—Capecitabine—breast cancer	9.6e-06	0.000193	CcSEcCtD
Pemetrexed—Conjunctivitis—Doxorubicin—breast cancer	9.59e-06	0.000193	CcSEcCtD
Pemetrexed—Nervous system disorder—Capecitabine—breast cancer	9.57e-06	0.000193	CcSEcCtD
Pemetrexed—Hepatitis—Epirubicin—breast cancer	9.57e-06	0.000193	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—breast cancer	9.56e-06	0.000192	CcSEcCtD
Pemetrexed—Diarrhoea—Fluorouracil—breast cancer	9.55e-06	0.000192	CcSEcCtD
Pemetrexed—Thrombocytopenia—Capecitabine—breast cancer	9.55e-06	0.000192	CcSEcCtD
Pemetrexed—Pharyngitis—Epirubicin—breast cancer	9.5e-06	0.000191	CcSEcCtD
Pemetrexed—Skin disorder—Capecitabine—breast cancer	9.48e-06	0.000191	CcSEcCtD
Pemetrexed—Urinary tract disorder—Epirubicin—breast cancer	9.45e-06	0.00019	CcSEcCtD
Pemetrexed—Urticaria—Paclitaxel—breast cancer	9.45e-06	0.00019	CcSEcCtD
Pemetrexed—Abdominal pain—Paclitaxel—breast cancer	9.4e-06	0.000189	CcSEcCtD
Pemetrexed—Body temperature increased—Paclitaxel—breast cancer	9.4e-06	0.000189	CcSEcCtD
Pemetrexed—Urethral disorder—Epirubicin—breast cancer	9.38e-06	0.000189	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Doxorubicin—breast cancer	9.33e-06	0.000188	CcSEcCtD
Pemetrexed—Anorexia—Capecitabine—breast cancer	9.3e-06	0.000187	CcSEcCtD
Pemetrexed—Vomiting—Mitoxantrone—breast cancer	9.27e-06	0.000187	CcSEcCtD
Pemetrexed—Vomiting—Irinotecan—breast cancer	9.27e-06	0.000187	CcSEcCtD
Pemetrexed—Dizziness—Fluorouracil—breast cancer	9.23e-06	0.000186	CcSEcCtD
Pemetrexed—Agranulocytosis—Doxorubicin—breast cancer	9.2e-06	0.000185	CcSEcCtD
Pemetrexed—Rash—Mitoxantrone—breast cancer	9.19e-06	0.000185	CcSEcCtD
Pemetrexed—Rash—Irinotecan—breast cancer	9.19e-06	0.000185	CcSEcCtD
Pemetrexed—Dermatitis—Irinotecan—breast cancer	9.18e-06	0.000185	CcSEcCtD
Pemetrexed—Dermatitis—Mitoxantrone—breast cancer	9.18e-06	0.000185	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Docetaxel—breast cancer	9.18e-06	0.000185	CcSEcCtD
Pemetrexed—Erythema multiforme—Epirubicin—breast cancer	9.05e-06	0.000182	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—breast cancer	9.04e-06	0.000182	CcSEcCtD
Pemetrexed—Vomiting—Gemcitabine—breast cancer	9.03e-06	0.000182	CcSEcCtD
Pemetrexed—Dyspnoea—Docetaxel—breast cancer	8.99e-06	0.000181	CcSEcCtD
Pemetrexed—Rash—Gemcitabine—breast cancer	8.95e-06	0.00018	CcSEcCtD
Pemetrexed—Dermatitis—Gemcitabine—breast cancer	8.95e-06	0.00018	CcSEcCtD
Pemetrexed—Eye disorder—Epirubicin—breast cancer	8.94e-06	0.00018	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—breast cancer	8.9e-06	0.000179	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—breast cancer	8.9e-06	0.000179	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Capecitabine—breast cancer	8.89e-06	0.000179	CcSEcCtD
Pemetrexed—Vomiting—Fluorouracil—breast cancer	8.88e-06	0.000179	CcSEcCtD
Pemetrexed—Dyspepsia—Docetaxel—breast cancer	8.87e-06	0.000179	CcSEcCtD
Pemetrexed—Hepatitis—Doxorubicin—breast cancer	8.85e-06	0.000178	CcSEcCtD
Pemetrexed—Rash—Fluorouracil—breast cancer	8.8e-06	0.000177	CcSEcCtD
Pemetrexed—Dermatitis—Fluorouracil—breast cancer	8.8e-06	0.000177	CcSEcCtD
Pemetrexed—Pharyngitis—Doxorubicin—breast cancer	8.79e-06	0.000177	CcSEcCtD
Pemetrexed—Decreased appetite—Docetaxel—breast cancer	8.76e-06	0.000176	CcSEcCtD
Pemetrexed—Hypersensitivity—Paclitaxel—breast cancer	8.76e-06	0.000176	CcSEcCtD
Pemetrexed—Urinary tract disorder—Doxorubicin—breast cancer	8.74e-06	0.000176	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—breast cancer	8.72e-06	0.000175	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Docetaxel—breast cancer	8.7e-06	0.000175	CcSEcCtD
Pemetrexed—Dyspnoea—Capecitabine—breast cancer	8.7e-06	0.000175	CcSEcCtD
Pemetrexed—Fatigue—Docetaxel—breast cancer	8.69e-06	0.000175	CcSEcCtD
Pemetrexed—Urethral disorder—Doxorubicin—breast cancer	8.68e-06	0.000175	CcSEcCtD
Pemetrexed—Nausea—Mitoxantrone—breast cancer	8.66e-06	0.000174	CcSEcCtD
Pemetrexed—Nausea—Irinotecan—breast cancer	8.66e-06	0.000174	CcSEcCtD
Pemetrexed—Pain—Docetaxel—breast cancer	8.62e-06	0.000173	CcSEcCtD
Pemetrexed—Constipation—Docetaxel—breast cancer	8.62e-06	0.000173	CcSEcCtD
Pemetrexed—Dyspepsia—Capecitabine—breast cancer	8.59e-06	0.000173	CcSEcCtD
Pemetrexed—Arrhythmia—Epirubicin—breast cancer	8.55e-06	0.000172	CcSEcCtD
Pemetrexed—Asthenia—Paclitaxel—breast cancer	8.53e-06	0.000172	CcSEcCtD
Pemetrexed—Decreased appetite—Capecitabine—breast cancer	8.48e-06	0.000171	CcSEcCtD
Pemetrexed—Alopecia—Epirubicin—breast cancer	8.46e-06	0.00017	CcSEcCtD
Pemetrexed—Nausea—Gemcitabine—breast cancer	8.44e-06	0.00017	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Capecitabine—breast cancer	8.42e-06	0.00017	CcSEcCtD
Pemetrexed—Fatigue—Capecitabine—breast cancer	8.41e-06	0.000169	CcSEcCtD
Pemetrexed—Pruritus—Paclitaxel—breast cancer	8.41e-06	0.000169	CcSEcCtD
Pemetrexed—Erythema multiforme—Doxorubicin—breast cancer	8.37e-06	0.000168	CcSEcCtD
Pemetrexed—Pain—Capecitabine—breast cancer	8.34e-06	0.000168	CcSEcCtD
Pemetrexed—Constipation—Capecitabine—breast cancer	8.34e-06	0.000168	CcSEcCtD
Pemetrexed—Erythema—Epirubicin—breast cancer	8.33e-06	0.000168	CcSEcCtD
Pemetrexed—Malnutrition—Epirubicin—breast cancer	8.33e-06	0.000168	CcSEcCtD
Pemetrexed—Nausea—Fluorouracil—breast cancer	8.29e-06	0.000167	CcSEcCtD
Pemetrexed—Eye disorder—Doxorubicin—breast cancer	8.27e-06	0.000167	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Docetaxel—breast cancer	8.24e-06	0.000166	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—breast cancer	8.23e-06	0.000166	CcSEcCtD
Pemetrexed—Dysgeusia—Epirubicin—breast cancer	8.16e-06	0.000164	CcSEcCtD
Pemetrexed—Diarrhoea—Paclitaxel—breast cancer	8.14e-06	0.000164	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Capecitabine—breast cancer	7.98e-06	0.000161	CcSEcCtD
Pemetrexed—Body temperature increased—Docetaxel—breast cancer	7.97e-06	0.00016	CcSEcCtD
Pemetrexed—Abdominal pain—Docetaxel—breast cancer	7.97e-06	0.00016	CcSEcCtD
Pemetrexed—Leukopenia—Methotrexate—breast cancer	7.97e-06	0.00016	CcSEcCtD
Pemetrexed—Arrhythmia—Doxorubicin—breast cancer	7.91e-06	0.000159	CcSEcCtD
Pemetrexed—Dizziness—Paclitaxel—breast cancer	7.86e-06	0.000158	CcSEcCtD
Pemetrexed—Alopecia—Doxorubicin—breast cancer	7.82e-06	0.000157	CcSEcCtD
Pemetrexed—Urticaria—Capecitabine—breast cancer	7.75e-06	0.000156	CcSEcCtD
Pemetrexed—Abdominal pain—Capecitabine—breast cancer	7.71e-06	0.000155	CcSEcCtD
Pemetrexed—Body temperature increased—Capecitabine—breast cancer	7.71e-06	0.000155	CcSEcCtD
Pemetrexed—Erythema—Doxorubicin—breast cancer	7.71e-06	0.000155	CcSEcCtD
Pemetrexed—Malnutrition—Doxorubicin—breast cancer	7.71e-06	0.000155	CcSEcCtD
Pemetrexed—Anaemia—Epirubicin—breast cancer	7.7e-06	0.000155	CcSEcCtD
Pemetrexed—Arthralgia—Methotrexate—breast cancer	7.58e-06	0.000152	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—breast cancer	7.58e-06	0.000152	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—breast cancer	7.58e-06	0.000152	CcSEcCtD
Pemetrexed—Vomiting—Paclitaxel—breast cancer	7.56e-06	0.000152	CcSEcCtD
Pemetrexed—Dysgeusia—Doxorubicin—breast cancer	7.55e-06	0.000152	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.53e-06	0.000151	CcSEcCtD
Pemetrexed—Rash—Paclitaxel—breast cancer	7.5e-06	0.000151	CcSEcCtD
Pemetrexed—Dermatitis—Paclitaxel—breast cancer	7.49e-06	0.000151	CcSEcCtD
Pemetrexed—Syncope—Epirubicin—breast cancer	7.47e-06	0.00015	CcSEcCtD
Pemetrexed—Leukopenia—Epirubicin—breast cancer	7.46e-06	0.00015	CcSEcCtD
Pemetrexed—Hypersensitivity—Docetaxel—breast cancer	7.43e-06	0.000149	CcSEcCtD
Pemetrexed—Loss of consciousness—Epirubicin—breast cancer	7.32e-06	0.000147	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—breast cancer	7.26e-06	0.000146	CcSEcCtD
Pemetrexed—Asthenia—Docetaxel—breast cancer	7.23e-06	0.000146	CcSEcCtD
Pemetrexed—Infection—Methotrexate—breast cancer	7.22e-06	0.000145	CcSEcCtD
Pemetrexed—Hypertension—Epirubicin—breast cancer	7.19e-06	0.000145	CcSEcCtD
Pemetrexed—Hypersensitivity—Capecitabine—breast cancer	7.19e-06	0.000145	CcSEcCtD
Pemetrexed—Pruritus—Docetaxel—breast cancer	7.13e-06	0.000144	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—breast cancer	7.12e-06	0.000143	CcSEcCtD
Pemetrexed—Anaemia—Doxorubicin—breast cancer	7.12e-06	0.000143	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—breast cancer	7.11e-06	0.000143	CcSEcCtD
Pemetrexed—Myalgia—Epirubicin—breast cancer	7.09e-06	0.000143	CcSEcCtD
Pemetrexed—Chest pain—Epirubicin—breast cancer	7.09e-06	0.000143	CcSEcCtD
Pemetrexed—Arthralgia—Epirubicin—breast cancer	7.09e-06	0.000143	CcSEcCtD
Pemetrexed—Nausea—Paclitaxel—breast cancer	7.06e-06	0.000142	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—breast cancer	7.06e-06	0.000142	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.04e-06	0.000142	CcSEcCtD
Pemetrexed—Asthenia—Capecitabine—breast cancer	7e-06	0.000141	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—breast cancer	6.92e-06	0.000139	CcSEcCtD
Pemetrexed—Syncope—Doxorubicin—breast cancer	6.91e-06	0.000139	CcSEcCtD
Pemetrexed—Pruritus—Capecitabine—breast cancer	6.9e-06	0.000139	CcSEcCtD
Pemetrexed—Leukopenia—Doxorubicin—breast cancer	6.9e-06	0.000139	CcSEcCtD
Pemetrexed—Diarrhoea—Docetaxel—breast cancer	6.9e-06	0.000139	CcSEcCtD
Pemetrexed—Anaphylactic shock—Epirubicin—breast cancer	6.8e-06	0.000137	CcSEcCtD
Pemetrexed—Oedema—Epirubicin—breast cancer	6.8e-06	0.000137	CcSEcCtD
Pemetrexed—Loss of consciousness—Doxorubicin—breast cancer	6.77e-06	0.000136	CcSEcCtD
Pemetrexed—Infection—Epirubicin—breast cancer	6.75e-06	0.000136	CcSEcCtD
Pemetrexed—Shock—Epirubicin—breast cancer	6.69e-06	0.000135	CcSEcCtD
Pemetrexed—Diarrhoea—Capecitabine—breast cancer	6.68e-06	0.000134	CcSEcCtD
Pemetrexed—Nervous system disorder—Epirubicin—breast cancer	6.67e-06	0.000134	CcSEcCtD
Pemetrexed—Dizziness—Docetaxel—breast cancer	6.66e-06	0.000134	CcSEcCtD
Pemetrexed—Thrombocytopenia—Epirubicin—breast cancer	6.66e-06	0.000134	CcSEcCtD
Pemetrexed—Hypertension—Doxorubicin—breast cancer	6.65e-06	0.000134	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—breast cancer	6.62e-06	0.000133	CcSEcCtD
Pemetrexed—Skin disorder—Epirubicin—breast cancer	6.6e-06	0.000133	CcSEcCtD
Pemetrexed—Myalgia—Doxorubicin—breast cancer	6.56e-06	0.000132	CcSEcCtD
Pemetrexed—Arthralgia—Doxorubicin—breast cancer	6.56e-06	0.000132	CcSEcCtD
Pemetrexed—Chest pain—Doxorubicin—breast cancer	6.56e-06	0.000132	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.52e-06	0.000131	CcSEcCtD
Pemetrexed—Anorexia—Epirubicin—breast cancer	6.48e-06	0.00013	CcSEcCtD
Pemetrexed—Dyspnoea—Methotrexate—breast cancer	6.48e-06	0.00013	CcSEcCtD
Pemetrexed—Dizziness—Capecitabine—breast cancer	6.45e-06	0.00013	CcSEcCtD
Pemetrexed—Vomiting—Docetaxel—breast cancer	6.41e-06	0.000129	CcSEcCtD
Pemetrexed—Dyspepsia—Methotrexate—breast cancer	6.39e-06	0.000129	CcSEcCtD
Pemetrexed—Rash—Docetaxel—breast cancer	6.35e-06	0.000128	CcSEcCtD
Pemetrexed—Dermatitis—Docetaxel—breast cancer	6.35e-06	0.000128	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—breast cancer	6.31e-06	0.000127	CcSEcCtD
Pemetrexed—Anaphylactic shock—Doxorubicin—breast cancer	6.29e-06	0.000127	CcSEcCtD
Pemetrexed—Oedema—Doxorubicin—breast cancer	6.29e-06	0.000127	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—breast cancer	6.27e-06	0.000126	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—breast cancer	6.26e-06	0.000126	CcSEcCtD
Pemetrexed—Infection—Doxorubicin—breast cancer	6.25e-06	0.000126	CcSEcCtD
Pemetrexed—Pain—Methotrexate—breast cancer	6.21e-06	0.000125	CcSEcCtD
Pemetrexed—Vomiting—Capecitabine—breast cancer	6.2e-06	0.000125	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Epirubicin—breast cancer	6.19e-06	0.000125	CcSEcCtD
Pemetrexed—Shock—Doxorubicin—breast cancer	6.19e-06	0.000125	CcSEcCtD
Pemetrexed—Nervous system disorder—Doxorubicin—breast cancer	6.17e-06	0.000124	CcSEcCtD
Pemetrexed—Thrombocytopenia—Doxorubicin—breast cancer	6.16e-06	0.000124	CcSEcCtD
Pemetrexed—Rash—Capecitabine—breast cancer	6.15e-06	0.000124	CcSEcCtD
Pemetrexed—Dermatitis—Capecitabine—breast cancer	6.15e-06	0.000124	CcSEcCtD
Pemetrexed—Skin disorder—Doxorubicin—breast cancer	6.11e-06	0.000123	CcSEcCtD
Pemetrexed—Dyspnoea—Epirubicin—breast cancer	6.06e-06	0.000122	CcSEcCtD
Pemetrexed—Anorexia—Doxorubicin—breast cancer	6e-06	0.000121	CcSEcCtD
Pemetrexed—Nausea—Docetaxel—breast cancer	5.99e-06	0.00012	CcSEcCtD
Pemetrexed—Dyspepsia—Epirubicin—breast cancer	5.98e-06	0.00012	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—breast cancer	5.94e-06	0.00012	CcSEcCtD
Pemetrexed—Decreased appetite—Epirubicin—breast cancer	5.91e-06	0.000119	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Epirubicin—breast cancer	5.87e-06	0.000118	CcSEcCtD
Pemetrexed—Fatigue—Epirubicin—breast cancer	5.86e-06	0.000118	CcSEcCtD
Pemetrexed—Pain—Epirubicin—breast cancer	5.81e-06	0.000117	CcSEcCtD
Pemetrexed—Constipation—Epirubicin—breast cancer	5.81e-06	0.000117	CcSEcCtD
Pemetrexed—Nausea—Capecitabine—breast cancer	5.8e-06	0.000117	CcSEcCtD
Pemetrexed—Urticaria—Methotrexate—breast cancer	5.77e-06	0.000116	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—breast cancer	5.74e-06	0.000116	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—breast cancer	5.74e-06	0.000116	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.73e-06	0.000115	CcSEcCtD
Pemetrexed—Dyspnoea—Doxorubicin—breast cancer	5.61e-06	0.000113	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Epirubicin—breast cancer	5.56e-06	0.000112	CcSEcCtD
Pemetrexed—Dyspepsia—Doxorubicin—breast cancer	5.54e-06	0.000111	CcSEcCtD
Pemetrexed—Decreased appetite—Doxorubicin—breast cancer	5.47e-06	0.00011	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Doxorubicin—breast cancer	5.43e-06	0.000109	CcSEcCtD
Pemetrexed—Fatigue—Doxorubicin—breast cancer	5.42e-06	0.000109	CcSEcCtD
Pemetrexed—Urticaria—Epirubicin—breast cancer	5.4e-06	0.000109	CcSEcCtD
Pemetrexed—Pain—Doxorubicin—breast cancer	5.38e-06	0.000108	CcSEcCtD
Pemetrexed—Constipation—Doxorubicin—breast cancer	5.38e-06	0.000108	CcSEcCtD
Pemetrexed—Abdominal pain—Epirubicin—breast cancer	5.37e-06	0.000108	CcSEcCtD
Pemetrexed—Body temperature increased—Epirubicin—breast cancer	5.37e-06	0.000108	CcSEcCtD
Pemetrexed—Hypersensitivity—Methotrexate—breast cancer	5.35e-06	0.000108	CcSEcCtD
Pemetrexed—Asthenia—Methotrexate—breast cancer	5.21e-06	0.000105	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Doxorubicin—breast cancer	5.14e-06	0.000104	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—breast cancer	5.14e-06	0.000103	CcSEcCtD
Pemetrexed—Hypersensitivity—Epirubicin—breast cancer	5.01e-06	0.000101	CcSEcCtD
Pemetrexed—Urticaria—Doxorubicin—breast cancer	5e-06	0.000101	CcSEcCtD
Pemetrexed—Abdominal pain—Doxorubicin—breast cancer	4.97e-06	0.0001	CcSEcCtD
Pemetrexed—Body temperature increased—Doxorubicin—breast cancer	4.97e-06	0.0001	CcSEcCtD
Pemetrexed—Diarrhoea—Methotrexate—breast cancer	4.97e-06	0.0001	CcSEcCtD
Pemetrexed—Asthenia—Epirubicin—breast cancer	4.88e-06	9.82e-05	CcSEcCtD
Pemetrexed—Pruritus—Epirubicin—breast cancer	4.81e-06	9.68e-05	CcSEcCtD
Pemetrexed—Dizziness—Methotrexate—breast cancer	4.8e-06	9.67e-05	CcSEcCtD
Pemetrexed—Diarrhoea—Epirubicin—breast cancer	4.65e-06	9.36e-05	CcSEcCtD
Pemetrexed—Hypersensitivity—Doxorubicin—breast cancer	4.63e-06	9.33e-05	CcSEcCtD
Pemetrexed—Vomiting—Methotrexate—breast cancer	4.62e-06	9.29e-05	CcSEcCtD
Pemetrexed—Rash—Methotrexate—breast cancer	4.58e-06	9.22e-05	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—breast cancer	4.58e-06	9.21e-05	CcSEcCtD
Pemetrexed—Asthenia—Doxorubicin—breast cancer	4.51e-06	9.08e-05	CcSEcCtD
Pemetrexed—Dizziness—Epirubicin—breast cancer	4.5e-06	9.05e-05	CcSEcCtD
Pemetrexed—Pruritus—Doxorubicin—breast cancer	4.45e-06	8.96e-05	CcSEcCtD
Pemetrexed—Vomiting—Epirubicin—breast cancer	4.32e-06	8.7e-05	CcSEcCtD
Pemetrexed—Nausea—Methotrexate—breast cancer	4.31e-06	8.68e-05	CcSEcCtD
Pemetrexed—Diarrhoea—Doxorubicin—breast cancer	4.3e-06	8.66e-05	CcSEcCtD
Pemetrexed—Rash—Epirubicin—breast cancer	4.29e-06	8.63e-05	CcSEcCtD
Pemetrexed—Dermatitis—Epirubicin—breast cancer	4.28e-06	8.62e-05	CcSEcCtD
Pemetrexed—Dizziness—Doxorubicin—breast cancer	4.16e-06	8.37e-05	CcSEcCtD
Pemetrexed—Nausea—Epirubicin—breast cancer	4.04e-06	8.13e-05	CcSEcCtD
Pemetrexed—Vomiting—Doxorubicin—breast cancer	4e-06	8.05e-05	CcSEcCtD
Pemetrexed—Rash—Doxorubicin—breast cancer	3.97e-06	7.98e-05	CcSEcCtD
Pemetrexed—Dermatitis—Doxorubicin—breast cancer	3.96e-06	7.97e-05	CcSEcCtD
Pemetrexed—Nausea—Doxorubicin—breast cancer	3.74e-06	7.52e-05	CcSEcCtD
Pemetrexed—ATIC—Metabolism—PIK3CD—breast cancer	3.17e-06	8.74e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—RB1—breast cancer	3.17e-06	8.71e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC2A1—breast cancer	3.17e-06	8.71e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1B1—breast cancer	3.16e-06	8.7e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BRAF—breast cancer	3.16e-06	8.69e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MED12—breast cancer	3.15e-06	8.66e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DPYD—breast cancer	3.15e-06	8.66e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—breast cancer	3.13e-06	8.62e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HSP90AA1—breast cancer	3.1e-06	8.53e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALDOA—breast cancer	3.1e-06	8.53e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAV1—breast cancer	3.09e-06	8.5e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TCF7L2—breast cancer	3.09e-06	8.49e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT2—breast cancer	3.07e-06	8.46e-05	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—breast cancer	3.07e-06	8.45e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP17A1—breast cancer	3.02e-06	8.31e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NCOA1—breast cancer	3.02e-06	8.3e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOA3—breast cancer	3.01e-06	8.28e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NOS3—breast cancer	3e-06	8.25e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS1—breast cancer	2.99e-06	8.22e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ENO1—breast cancer	2.99e-06	8.22e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A2—breast cancer	2.99e-06	8.22e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HSP90AA1—breast cancer	2.98e-06	8.19e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—STK11—breast cancer	2.97e-06	8.18e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP19A1—breast cancer	2.97e-06	8.18e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CD—breast cancer	2.95e-06	8.13e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2D6—breast cancer	2.93e-06	8.07e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCG2—breast cancer	2.93e-06	8.05e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTR—breast cancer	2.93e-06	8.05e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CPT1A—breast cancer	2.93e-06	8.05e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SERPINE1—breast cancer	2.92e-06	8.04e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PRL—breast cancer	2.89e-06	7.97e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NCOA2—breast cancer	2.88e-06	7.92e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HPGDS—breast cancer	2.87e-06	7.9e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ADAM10—breast cancer	2.85e-06	7.85e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HBA1—breast cancer	2.85e-06	7.85e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—RB1—breast cancer	2.83e-06	7.79e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1B—breast cancer	2.82e-06	7.77e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CG—breast cancer	2.81e-06	7.74e-05	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—breast cancer	2.81e-06	7.73e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FASN—breast cancer	2.79e-06	7.68e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS3—breast cancer	2.79e-06	7.67e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ACHE—breast cancer	2.78e-06	7.66e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTT1—breast cancer	2.78e-06	7.66e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCHE—breast cancer	2.78e-06	7.65e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF10—breast cancer	2.78e-06	7.64e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CB—breast cancer	2.77e-06	7.62e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MDM2—breast cancer	2.77e-06	7.61e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—COMT—breast cancer	2.76e-06	7.61e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTP1—breast cancer	2.75e-06	7.57e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC5A5—breast cancer	2.74e-06	7.55e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—breast cancer	2.74e-06	7.55e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMOX1—breast cancer	2.71e-06	7.47e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ITPR1—breast cancer	2.71e-06	7.45e-05	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.7e-06	7.43e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND1—breast cancer	2.69e-06	7.41e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PDGFA—breast cancer	2.68e-06	7.37e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NQO1—breast cancer	2.65e-06	7.29e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A1—breast cancer	2.65e-06	7.29e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MDM2—breast cancer	2.65e-06	7.28e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFBR2—breast cancer	2.64e-06	7.26e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RAF1—breast cancer	2.64e-06	7.26e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP17A1—breast cancer	2.63e-06	7.25e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—breast cancer	2.61e-06	7.18e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS1—breast cancer	2.61e-06	7.18e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ENO1—breast cancer	2.61e-06	7.18e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1A—breast cancer	2.61e-06	7.17e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCB1—breast cancer	2.6e-06	7.17e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ITPR1—breast cancer	2.6e-06	7.15e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP3A4—breast cancer	2.58e-06	7.11e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB4—breast cancer	2.58e-06	7.1e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT5A—breast cancer	2.58e-06	7.1e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTOR—breast cancer	2.57e-06	7.08e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CB—breast cancer	2.57e-06	7.08e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD4—breast cancer	2.57e-06	7.07e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2D6—breast cancer	2.56e-06	7.04e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TYMS—breast cancer	2.56e-06	7.04e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—breast cancer	2.55e-06	7.02e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1B1—breast cancer	2.54e-06	6.99e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NCOR1—breast cancer	2.53e-06	6.96e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PLA2G4A—breast cancer	2.53e-06	6.96e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—breast cancer	2.53e-06	6.96e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1B—breast cancer	2.52e-06	6.95e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOA2—breast cancer	2.51e-06	6.91e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SMAD4—breast cancer	2.5e-06	6.88e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HSP90AA1—breast cancer	2.49e-06	6.86e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CD—breast cancer	2.47e-06	6.81e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—breast cancer	2.46e-06	6.78e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—breast cancer	2.44e-06	6.72e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HES1—breast cancer	2.44e-06	6.71e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—FASN—breast cancer	2.43e-06	6.7e-05	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—breast cancer	2.43e-06	6.7e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NCOR1—breast cancer	2.43e-06	6.68e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCHE—breast cancer	2.42e-06	6.67e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NCOA1—breast cancer	2.42e-06	6.67e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX1—breast cancer	2.42e-06	6.66e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1B—breast cancer	2.42e-06	6.65e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MDM2—breast cancer	2.41e-06	6.64e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND1—breast cancer	2.41e-06	6.63e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF1—breast cancer	2.4e-06	6.6e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1A1—breast cancer	2.4e-06	6.6e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC5A5—breast cancer	2.39e-06	6.59e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTEN—breast cancer	2.39e-06	6.58e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP19A1—breast cancer	2.39e-06	6.58e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—STK11—breast cancer	2.39e-06	6.58e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NRG1—breast cancer	2.38e-06	6.55e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ERCC2—breast cancer	2.38e-06	6.54e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—H2AFX—breast cancer	2.36e-06	6.51e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND1—breast cancer	2.35e-06	6.47e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NOS3—breast cancer	2.34e-06	6.43e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1A—breast cancer	2.33e-06	6.41e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NQO1—breast cancer	2.31e-06	6.37e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A1—breast cancer	2.31e-06	6.37e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CTNNB1—breast cancer	2.28e-06	6.28e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERCC2—breast cancer	2.28e-06	6.28e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—breast cancer	2.27e-06	6.26e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP3A4—breast cancer	2.26e-06	6.21e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—breast cancer	2.23e-06	6.15e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB3—breast cancer	2.23e-06	6.14e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1A—breast cancer	2.23e-06	6.14e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR2—breast cancer	2.23e-06	6.13e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTEN—breast cancer	2.22e-06	6.12e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK3—breast cancer	2.22e-06	6.11e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—COMT—breast cancer	2.22e-06	6.11e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1B1—breast cancer	2.22e-06	6.1e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTP1—breast cancer	2.21e-06	6.08e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1B—breast cancer	2.2e-06	6.06e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMOX1—breast cancer	2.18e-06	6e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ITPR1—breast cancer	2.18e-06	5.99e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HSP90AA1—breast cancer	2.17e-06	5.98e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—breast cancer	2.16e-06	5.95e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CB—breast cancer	2.16e-06	5.93e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—breast cancer	2.14e-06	5.9e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TERT—breast cancer	2.14e-06	5.88e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—breast cancer	2.14e-06	5.88e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOA1—breast cancer	2.12e-06	5.82e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND1—breast cancer	2.1e-06	5.78e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCB1—breast cancer	2.09e-06	5.76e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP19A1—breast cancer	2.08e-06	5.74e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—STK11—breast cancer	2.08e-06	5.74e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR1—breast cancer	2.08e-06	5.71e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SRC—breast cancer	2.06e-06	5.68e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAV1—breast cancer	2.06e-06	5.67e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TYMS—breast cancer	2.06e-06	5.66e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HIF1A—breast cancer	2.04e-06	5.63e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1A—breast cancer	2.03e-06	5.6e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PLA2G4A—breast cancer	2.03e-06	5.59e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—breast cancer	2.03e-06	5.59e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NCOR1—breast cancer	2.03e-06	5.59e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—breast cancer	1.99e-06	5.47e-05	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—breast cancer	1.99e-06	5.47e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK3—breast cancer	1.99e-06	5.47e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CAV1—breast cancer	1.98e-06	5.44e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX1—breast cancer	1.95e-06	5.35e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK3—breast cancer	1.94e-06	5.33e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—COMT—breast cancer	1.94e-06	5.33e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—breast cancer	1.93e-06	5.32e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTP1—breast cancer	1.93e-06	5.31e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1A1—breast cancer	1.93e-06	5.3e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ERCC2—breast cancer	1.91e-06	5.26e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMOX1—breast cancer	1.9e-06	5.24e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK3—breast cancer	1.9e-06	5.23e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ITPR1—breast cancer	1.9e-06	5.22e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—breast cancer	1.89e-06	5.19e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CG—breast cancer	1.88e-06	5.17e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTEN—breast cancer	1.86e-06	5.13e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS2—breast cancer	1.86e-06	5.12e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—breast cancer	1.85e-06	5.09e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TGFB1—breast cancer	1.84e-06	5.07e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOTCH1—breast cancer	1.84e-06	5.07e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCB1—breast cancer	1.83e-06	5.03e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—breast cancer	1.81e-06	4.98e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KIT—breast cancer	1.8e-06	4.96e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APC—breast cancer	1.8e-06	4.96e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—breast cancer	1.8e-06	4.94e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGF—breast cancer	1.78e-06	4.9e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—breast cancer	1.77e-06	4.88e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOR1—breast cancer	1.77e-06	4.88e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLA2G4A—breast cancer	1.77e-06	4.88e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK3—breast cancer	1.73e-06	4.77e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KRAS—breast cancer	1.71e-06	4.7e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX1—breast cancer	1.7e-06	4.67e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BRAF—breast cancer	1.69e-06	4.66e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—breast cancer	1.69e-06	4.64e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—breast cancer	1.69e-06	4.64e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1A1—breast cancer	1.68e-06	4.62e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ERCC2—breast cancer	1.67e-06	4.59e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAV1—breast cancer	1.66e-06	4.56e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CD—breast cancer	1.65e-06	4.54e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT2—breast cancer	1.65e-06	4.54e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—breast cancer	1.63e-06	4.48e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—breast cancer	1.59e-06	4.37e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CD—breast cancer	1.58e-06	4.36e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—breast cancer	1.57e-06	4.32e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—breast cancer	1.57e-06	4.31e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SERPINE1—breast cancer	1.57e-06	4.31e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NOS3—breast cancer	1.56e-06	4.29e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CG—breast cancer	1.51e-06	4.15e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS3—breast cancer	1.5e-06	4.11e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—breast cancer	1.45e-06	4e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAV1—breast cancer	1.45e-06	3.98e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CB—breast cancer	1.44e-06	3.96e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—breast cancer	1.43e-06	3.92e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MDM2—breast cancer	1.42e-06	3.9e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RAF1—breast cancer	1.41e-06	3.89e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—breast cancer	1.4e-06	3.85e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—breast cancer	1.39e-06	3.82e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—breast cancer	1.38e-06	3.81e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTOR—breast cancer	1.38e-06	3.8e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CB—breast cancer	1.38e-06	3.8e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—breast cancer	1.38e-06	3.79e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—breast cancer	1.38e-06	3.79e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—breast cancer	1.37e-06	3.76e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CD—breast cancer	1.33e-06	3.65e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CG—breast cancer	1.32e-06	3.62e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—breast cancer	1.31e-06	3.62e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—breast cancer	1.31e-06	3.6e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1B—breast cancer	1.3e-06	3.56e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—breast cancer	1.28e-06	3.53e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NOS3—breast cancer	1.25e-06	3.45e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTEN—breast cancer	1.24e-06	3.42e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CTNNB1—breast cancer	1.22e-06	3.37e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1A—breast cancer	1.2e-06	3.29e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTEN—breast cancer	1.19e-06	3.28e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CD—breast cancer	1.16e-06	3.18e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CB—breast cancer	1.16e-06	3.18e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—breast cancer	1.15e-06	3.15e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—breast cancer	1.14e-06	3.14e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SRC—breast cancer	1.11e-06	3.04e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NOS3—breast cancer	1.09e-06	3.01e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—breast cancer	1.07e-06	2.95e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—breast cancer	1.07e-06	2.94e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK3—breast cancer	1.02e-06	2.8e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CB—breast cancer	1.01e-06	2.78e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—breast cancer	9.99e-07	2.75e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTEN—breast cancer	9.99e-07	2.75e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—breast cancer	9.91e-07	2.73e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFB1—breast cancer	9.89e-07	2.72e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—breast cancer	9.69e-07	2.67e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KRAS—breast cancer	9.16e-07	2.52e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—breast cancer	8.77e-07	2.41e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTEN—breast cancer	8.72e-07	2.4e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—breast cancer	8.41e-07	2.32e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—breast cancer	7.78e-07	2.14e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—breast cancer	7.45e-07	2.05e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—breast cancer	7.16e-07	1.97e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—breast cancer	7.05e-07	1.94e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—breast cancer	6.87e-07	1.89e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—breast cancer	6.15e-07	1.69e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—breast cancer	5.76e-07	1.58e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—breast cancer	5.02e-07	1.38e-05	CbGpPWpGaD
